Revista Científica Salud Uninorte, Vol 34, No 2 (2018)

Tamaño de la letra:  Pequeña  Mediana  Grande

Alteration of the sexual response cycle in women using combined oral contraceptives

Franklin José Espitia De La Hoz


Objective To estimate the effect of female sexuality due to the use of the contraceptive combination estradiol valerate / Dienogest against Ethinylestradiol / Drospirenone.

Material and methods A controlled, randomized, unblinded clinical trial was carried out on 174 women, between 18 and 39 years of age, who underwent two hormonal contraceptive options with estradiol valerate / Dienogest and ethinylestradiol / Drospirenone; in a private clinic in Armenia, Quindío, between 2013 and 2017. The female sexual function index (IFSF) was used to analyze the sexual function of the participating women; at the beginning, at six, at eighteen and thirty-six months after the start of the contraceptive.

Results At the end of the study, the contraceptive combination estradiol valerate / Dienogest was a less aggressive therapy in the alteration of the sexual response cycle of the users, while the ethinylestradiol / drospirenone combination significantly affects the desire and excitement with lower scores in the IFSF.

Conclusions The results indicate that the estradiol valerate / Dienogest combination affects the desire, arousal and IFSF score less than the ethinylestradiol / drospirenone combination.

Palabras Clave / Keywords

Androgens, Contraceptive Agents, Women, Sexuality, Testosterone

Tipo de Artículo

Artículo de investigación científica y tecnológica

DOI (Digital Object Identifier)

Texto completo: PDF HTML


  • No hay Refbacks actualmente.

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.